<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004076A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004076</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14014413</doc-number><date>20130830</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>CN</country><doc-number>201010181623.5</doc-number><date>20100525</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>14</main-group><subgroup>535</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>14</main-group><subgroup>535</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>424 851</main-classification><further-classification>530395</further-classification><further-classification>530362</further-classification><further-classification>5303873</further-classification><further-classification>435 694</further-classification><further-classification>525 541</further-classification></classification-national><invention-title id="d0e61">RECOMBINANT HUMAN G-CSF DIMER AND USE THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASES</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13114035</doc-number><date>20110523</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8557546</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14014413</doc-number></document-id></child-doc></relation></continuation></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>GENERON (SHANGHAI) CORPORATION LTD.</orgname><address><city>SHANGHAI</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>YAN</last-name><first-name>Xiaoqiang</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>HUANG</last-name><first-name>Zhihua</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>YANG</last-name><first-name>Hongzhou</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>SUN</last-name><first-name>Bill N.C.</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>HUANG</last-name><first-name>Yuliang</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>GENERON (SHANGHAI) CORPORATION LTD.</orgname><role>03</role><address><city>SHANGHAI</city><country>CN</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural injury in animal, this invention can be used to protect neurons with the use of rhG-CSF dimer such that function of injured nerves can be restored. Serum half-life of G-CSF dimer of this invention is prolonged and the biological activity thereof is increased.</p></abstract></us-patent-application>